Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-25T07:03:01.509Z Has data issue: false hasContentIssue false
  • English
  • Français

Loss of Heterozygosity Analysis of Chromosomes 9, 10 and 17 in Gliomas in Families

Published online by Cambridge University Press:  18 September 2015

Christopher J. Watling ,
Donald J. van Meyel ,
David A. Ramsay ,
David R. Macdonald  and
J. Gregory Cairncross
Christopher J. Watling
Affiliation:
Department of Clinical Neurological Sciences, University of Western Ontario and the London Regional Cancer Centre, London
Donald J. van Meyel
Affiliation:
Department of Microbiology and Immunology, University of Western Ontario and the London Regional Cancer Centre, London Department of Oncology, University of Western Ontario and the London Regional Cancer Centre, London
David A. Ramsay
Affiliation:
Department of Clinical Neurological Sciences, University of Western Ontario and the London Regional Cancer Centre, London Department of Pathology, University of Western Ontario and the London Regional Cancer Centre, London
David R. Macdonald
Affiliation:
Department of Clinical Neurological Sciences, University of Western Ontario and the London Regional Cancer Centre, London Department of Oncology, University of Western Ontario and the London Regional Cancer Centre, London
J. Gregory Cairncross*
Affiliation:
Department of Clinical Neurological Sciences, University of Western Ontario and the London Regional Cancer Centre, London Department of Microbiology and Immunology, University of Western Ontario and the London Regional Cancer Centre, London Department of Oncology, University of Western Ontario and the London Regional Cancer Centre, London
*
London Regional Cancer Centre, 790 Commissioners Road East, London, Ontario, Canada N6A 4L6
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Studies of sporadic malignant gliomas have identified structural abnormalities in a number of chromosomal regions, especially losses of DNA on 9p, 10 and 17p.

Purpose:

We undertook the following molecular analysis in families with glioma to determine the frequency of chromosomal losses in these regions and to test the utility of microsatellite markers in demonstrating losses of heterozygosity.

Methods:

Genomic DNA was extracted from tumor tissue and venous blood from 20 patients with a family history of glioma. Dinucleotide repeat polymorphisms (microsatellites) were analyzed by polymerase chain reaction to assess loss of constitutional heterozygosity (LOH) on 9p, 10 and 17p. Three polymorphic markers on chromosome 9 (D9S104, D9S161, D9S165), one on chromosome 10 (D10S209), and two on 17p (D17S786, D17S796) were used. Autoradiographic films were analyzed for LOH after radioactively labelled polymerase chain reaction products were resolved on denaturing formamide-acrylamide gels.

Results:

Of 20 patients informative for at least one of three chromosome 9 markers, 12 (60%) showed LOH at one or more loci; of 9 informative for the chromosome 10 marker, 4 (44%) showed LOH; and of 16 informative for at least one of two chromosome 17 markers, 7 (44%) showed LOH at one or both loci. These LOH rates do not include instances of tumor nullizygosity (0 – 35%) and therefore represent minimum frequencies of chromosomal losses at these loci.

Conclusions:

Microsatellite markers can be used to detect LOH in archival glioma tissue. As in sporadic gliomas, frequent LOH was observed on 9p (9p21-22), 10 and 17p, supporting the notion that these regions may harbour tumor suppressor genes important in glioma development. Further work will be required to determine whether the proportion of LOH in these chromosomal regions is higher in familial gliomas than sporadic ones, as might occur with an inherited suppressor gene conferring susceptibility to gliomas in families.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 22 , Issue 1 , February 1995 , pp. 17 - 21
Copyright
Copyright © Canadian Neurological Sciences Federation 1995

References

1. Ikizler, Y, van Meyel DJ, Ramsay, DA, et al. Gliomas in families. Can J Neurol Sci 1992; 19:492–497.CrossRefGoogle ScholarPubMed
2. Eng, C, Ponder, BAJ.The role of gene mutations in the genesis of familial cancers. FASEB J 1993; 7: 910–919.CrossRefGoogle ScholarPubMed
3. Rasheed, BKA, Bigner, SH.Genetic alterations in glioma and medulloblastoma. Cancer Metastasis Rev 1991; 10: 289–299.CrossRefGoogle ScholarPubMed
4. Weinberg, RA.Tumor suppressor genes. Science 1991; 254: 1138–1146.CrossRefGoogle ScholarPubMed
5. Olopade, OI, Jenkins, RB, Ransom, DT, et al. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 1992; 52: 2523–2529.Google ScholarPubMed
6. James, CD, He, J, Carlbom, E, et al. Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. Cancer Res 1991; 51: 1684–1688.Google ScholarPubMed
7. Watanabe, K, Nagai, M, Wakai, S, et al. Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma. Acta Neuropathol 1990; 80:251–254.CrossRefGoogle ScholarPubMed
8. James, CD, Carlbom, E, Damanski, JP, et al. Clonal genomic alterations in glioma malignancy stages. Cancer Res 1988; 48: 5546–5551.Google ScholarPubMed
9. James, CD, Carlbom, E, Nordenskjold, M, et al. Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA 1989; 86: 2858–2862.CrossRefGoogle ScholarPubMed
10. Fults, D, Tippets, RH, Thomas, GA, et al. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Cancer Res 1989; 49:6572–6577.Google ScholarPubMed
11. Fults, D, Brockmeyer, D, Tullous, MW, et al. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 1992; 52: 674–679.Google ScholarPubMed
12. von Deimling, A, Eibl, RH, Ohgaki, H, et al. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 1992; 52: 2987–2990.Google ScholarPubMed
13. El-Azouzi, M, Chung, RY, Farmer, GE, et al. Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc Natl Acad Sci USA 1989; 86: 7186–7190.CrossRefGoogle ScholarPubMed
14. Kamb, A, Gruis, NA, Weaver-Feldhaus, J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436–440.CrossRefGoogle ScholarPubMed
15. Weber, JL, May, PE.Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989; 44:388–396.Google ScholarPubMed
16. Liu, M, Hauge, X, Sharma, V.Shadow bands seen when typing polymorphic dinucleotide repeats: some causes and cures. Bio Techniques 1993; 15(2): 280–284.Google Scholar
17. Collins, VP, James, CD.Gene and chromosomal alterations associated with the development of human gliomas. FASEB J 1993; 7: 926–930.CrossRefGoogle ScholarPubMed
18. Weissenbach, J, Gyapay, G, Dib, C, et al. A second-generation linkage map of the human genome. Nature 1992; 359: 794–801.CrossRefGoogle ScholarPubMed
19. NIH/CEPH Collaborative Mapping Group. A comprehensive genetic linkage map of the human genome. Science 1992; 258: 67–86.CrossRefGoogle Scholar
20. Miyakoshi, J, Dobler, KD, Allalunis-Turner, J, et al. Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons. Cancer Res 1990; 50: 278–283.Google ScholarPubMed
21. James, CD, He, J, Collins, VP, et al. Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group. Cancer Res 1993; 53: 3674–3676.Google ScholarPubMed
22. Olopade, OI, Bahlander, SK, Pomykala, H, et al. Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics 1992; 14: 437–443.CrossRefGoogle ScholarPubMed
23. Nobori, T, Miura, K, Wu, DJ, et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753–756.CrossRefGoogle ScholarPubMed
24. Pershouse, MA, Stubblefield, E, Hadi, A, et al. Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res 1993; 53(20): 5043–5050.Google ScholarPubMed
25. Nigro, JM, Baker, SJ, Preisinger, AC, et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342: 705–708.CrossRefGoogle Scholar